Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis.

Although results from multiple-treatment meta-analysis failed to reach significance as to comparisons among timing groups, at least, that could indicate the absence of increased adverse events, suggesting that BMSs therapy is safe. 4.4.

also in 4,113 other papers

Interestingly, after further dividing 1~7 days' group into 1~3 and 4~7 days' group, the former only showed a trend toward improved LVEF, but the latter still resulted in a 3.05% (95% CI, 0.92~5.25) increase for 6-month follow-up and 4.18% (95% CI, 2.30~5.84) increase for 12-month follow-up in LVEF, respectively ( Figure 2(d) ).

also in 53,322 other papers